A study co-authored by WashU Medicine Cardiovascular Division faculty members Joshua D. Mitchell, MD, MSCI, Ali Javaheri, MD, PhD, and Jonathan D. Moreno, MD, PhD, evaluated the availability and delivery of cardiac amyloidosis care across the U.S. Department of Veterans Affairs (VA) health system.
Anubha Agarwal, MD, MSc, of the WashU Cardiovascular Division, contributed to an international expert consensus document updating the global definition of heart failure and providing a unified framework for prevention, diagnosis and treatment.
The Barnes-Jewish Hospital Antimicrobial Stewardship Program (BJH-ASP) has been renewed as an Infectious Diseases Society of America (IDSA) Antimicrobial Stewardship Center of Excellence. This designation recognizes hospitals that consistently provide high-quality stewardship services, advance innovative stewardship practices, and demonstrate a strong commitment to improving antimicrobial use and reducing resistance.
The demand for specialized serious illness and end-of-life care continues to grow as our population ages and more people live longer with complex chronic conditions. As nearly 20 percent of the U.S. population are now baby boomers, the need for high-quality palliative and hospice care has never been greater.
The START Strong Survivorship Clinic connects newly diagnosed patients with nutrition, physical therapy, emotional support, and resources to help them navigate treatment from the very beginning.
For 20 years, the WashU Medicine Diabetes Center at Barnes-Jewish Hospital has provided comprehensive, patient-centered care for people living with diabetes while advancing education and research, embracing innovation, and expanding access to specialized treatment.
Aditi Ramakrishnan, MD, Assistant Professor of Medicine in the Division of Infectious Diseases, recognized early in her research career that community engagement would be critical. The Center for Community Health Partnership and Research talked with Aditi about her journey.
Congratulations on being recognized for being at the 98% for patient experience at WashU Medicine. This is an outstanding achievement and recognizes your commitment to delivering patient centered care, acknowledges your excellent bedside manner, meticulous attention to detail, exceptional communication skills and tremendous clinical knowledge and expertise. You take care of a large number of […]
The Department of Medicine is proud to announce that over 170 of our faculty have been selected for the 2026 Castle Connolly Top Doctors® list. The Top Doctors® selection process is entirely merit-based. Doctors cannot pay to be listed. These doctors are best-in-class healthcare providers, embodying excellence in clinical care as well as interpersonal skills. […]
The Centers for Disease Control and Prevention is working with state and federal partners to investigate several outbreaks of cyclosporiasis, a gastrointestinal disease caused by the microscopic parasite Cyclospora cayetanensis. In a health alert published July 14, the CDC reported 1,645 known cases of cyclosporiasis nationwide May to July of 2026.
ST. LOUIS, Mo. (First Alert 4) -A cutting-edge procedure for treating sickle cell disease is changing lives in the St. Louis area, where an estimated 1,200 people have the debilitating blood disorder. Damon Williams, 48, is the first adult patient in the St. Louis region to receive a new gene therapy treatment for sickle cell […]
Hookworms, intestinal parasites that infect hundreds of millions of people in under-resourced tropical regions around the globe, have evolved to survive inside the human gut for years, secreting molecules that enable co-existence with their hosts. Now, researchers at Washington University School of Medicine in St. Louis have harnessed that biological mechanism for potential human benefit, […]
At WashU Medicine, virologist Jacco Boon, PhD, Division of Infectious Diseases, is turning his attention to a growing but often overlooked public health concern: tick-borne viruses in Missouri and across the Midwest. Boon’s path to studying some of the world’s smallest—and most complex—infectious agents began long before his work in Missouri. Originally from the Netherlands, […]
SAN DIEGO, California – VANCOUVER, British Columbia, May 27, 2026 – Phoenix Molecular Designs (PhoenixMD), a clinical-stage precision oncology company developing first-in-class RSK kinase inhibitors, today announced the expansion of its lead asset PMD-026 into a second clinical indication with the initiation of Dauntless-3, an investigator-initiated Phase 1 trial in myelofibrosis at Washington University School […]
What began as a small, hard-to-see mole on Deborah Dieman’s ankle eventually led to a diagnosis of Stage IV melanoma. Despite surgery and standard immunotherapy, her cancer spread aggressively, and she was told she had only months to live.
David Moore is living his best life, thanks to his dedicated team of specialists at WashU Medicine and BJC HealthCare.
For highly aggressive types of blood cancer, stem cell transplantation is often the only potentially curative therapy, yet even after a transplant, these cancers often return.
A personalized vaccine to treat glioblastoma, a fast-growing and incurable brain cancer that affects four in 100,000 people in the U.S., is safe and elicits robust and broad immune responses that appears to increase recurrence-free survival in a subset of patients after surgery, according to an early-stage clinical trial co-led by researchers at Washington University […]
With GLP-1 weight-loss drugs becoming more common, doctors are working to better understand how they affect the body—and what patients can expect beyond weight loss. Dr. Samuel Klein with WashU Medicine is leading a clinical trial exploring those effects, from changes in metabolism and health markers to what happens as people lose significant weight. First […]
A new multinational study finds that individuals with poor mental health consistently report lower-quality healthcare experiences across diverse health systems. Published May 5 in PLOS Medicine, the study was led by Margaret E. Kruk, MD, of Washington University School of Medicine in St. Louis, in collaboration with an international team of researchers.
The American Heart Association and the American College of Cardiology have released new guidance on cholesterol management, as heart disease remains the leading cause of death nationwide.
Cardiologists and cardiac surgeons from WashU Medicine’s cardiovascular and cardiothoracic surgery divisions used the ShortCut device to successfully treat a high-risk patient with a failing heart valve.
A cell-based immunotherapy designed to treat rare and aggressive types of blood cancer has been granted Breakthrough Therapy designation by the U.S. Food and Drug Administration (FDA). Developed by researchers at Washington University School of Medicine in St. Louis, this innovative CAR-T cell therapy is licensed to Wugen, a WashU Medicine startup biotechnology company based […]
The WashU Medicine Amyloid Center of Excellence has been selected as one of just 10 centers nationwide to participate in the American Heart Association’s ATTR-CM Discovery Initiative, a three-year program aimed at transforming care for patients with transthyretin amyloid cardiomyopathy (ATTR-CM).
When well-known St. Louis radio broadcaster John Carney, 61, experienced a sudden, life-threatening aortic dissection, WashU Medicine experts at Barnes-Jewish Hospital identified the hidden genetic condition behind it—and set out to save his life.
On behalf of INTERLINK COE Networks & Programs, a message of congratulations is extended to the Liver and Lung programs for qualifying for ELITE status within the credentialed Programs of Excellence transplant network. INTERLINK ranks transplant programs against their national peers, and only a select few achieve this distinction. ELITE status represents superior performance across […]
In the United States and around the world, public health is under enormous strain. Entire divisions at the Centers for Disease Control and Prevention have been dismantled; the U.S. Agency for International Development (USAID) has been shuttered; science funding through the National Institutes of Health has been slashed and thousands of public health jobs cut.
The Department of Medicine is proud to announce that 170 of our faculty have been selected for the 2025 Castle Connolly Top Doctors® list. The Top Doctors® selection process is entirely merit-based. Doctors cannot pay to be listed. These doctors are best-in-class healthcare providers, embodying excellence in clinical care as well as interpersonal skills. More […]
Since it was first detected in the U.S. in 2014, H5N1 avian influenza, commonly known as bird flu, has jumped from wild birds to farm animals and then to people, causing more than 70 human cases in the U.S. since 2022, including two fatalities. The virus continues to circulate among animals, giving it the opportunity […]
When Marcy Lagarde, 42, of Raymore, Missouri, felt sudden excruciating pain in her left arm and had trouble lying down she knew something wasn’t right. Marcy has Marfan syndrome, a genetic condition that weakens the body’s connective tissue.
At 82 years old, Lois Miles was one of the first patients at Barnes-Jewish Hospital to receive a transcatheter tricuspid valve implant, a groundbreaking procedure performed in 2024. It’s one more way the hospital and its academic physician partner, WashU Medicine, are helping patients with valve disease.
An in-home mammalian meat reintroduction protocol was feasible and safe among patients with alpha-gal syndrome who had declining alpha-gal IgE titers and avoided red meat, according to study results.
When Ashley Brooks, RN, BSN, was born, the first hint her parents received that something was out of the ordinary was that nurses didn’t bring their infant daughter from the nursery to their room when it was time to eat. She had been taken to the hospital’s neonatal intensive care unit.
Makenna Dixon remembers all the appointments during her childhood. Her mother suffered from autoimmune diseases that required countless trips to physical therapy. As her health conditions worsened, Dixon’s mom could no longer work a full-time job, and the lack of insurance through an employer made therapy one financial challenge among many.
The number of Hepatitis C infections in pregnancy increased tenfold from 2000 to 2019. Legislative solutions helped paved the way for a new ‘meds to beds’ program at Washington University School of Medicine in St. Louis that’s bringing better access to a cure
The Foundation for Barnes-Jewish Hospital is pleased to announce it has raised $2 million to establish PREVENT, a multidisciplinary program at WashU Medicine and Barnes-Jewish Hospital focused on prevention and early detection of stomach and pancreatic cancers.
Radha Devi, MD, Timothy Evans, MD, and Rob Young, MD, have been spearheading the ADEPT (Achieving Diagnostic Excellence Through Prevention and Teamwork) initiative at WashU in collaboration with Colorado’s Institute for Healthcare Quality, Safety, and Efficiency (IHQSE). Along with 14 other academic medical institutions across the United States, the WashU ADEPT team is leading the […]
Cardiovascular disease (CVD) is the leading cause of death and disability worldwide. These conditions, which include atherosclerosis, heart attack, stroke, and heart failure, cause one in three deaths globally and one in five in the United States. Beyond that stark reality, those living with the conditions may contend with disability, psychological distress, financial burden, and […]
Complicated Urinary Tract Infections (cUTI): Clinical Guidelines for Treatment and Management IDSA has released the first IDSA guidelines on management and treatment of complicated urinary tract infections (cUTIs). These guidelines provide practical advice for clinicians who manage patients with cUTIs in inpatient and outpatient settings. Barbara Trautner, MD, PhD, Co-Chief, WashU Medicine Division of Infectious […]
A groundbreaking clinical trial utilizing technology developed previously by Jeffrey R. Millman, PhD has reported promising new findings in the treatment of type 1 diabetes (T1D). The study, conducted by Vertex Pharmaceuticals, evaluated a stem cell-derived islet (SC-islet) replacement therapy known as Zimislecel. In this Phase 1/2 trial, researchers implanted SC-islets into patients with T1D to replace the […]
As the opioid epidemic has worsened in the United States, prevalence of hepatitis C has also increased. Hepatitis C is a bloodborne virus that damages the liver. It is mainly spread through sharing needles or other injection equipment and can also be passed from a mother to baby during pregnancy or childbirth. It can be […]
Early this year, not long after President Donald Trump took office, his administration started terminating grants awarded by the National Institutes of Health (NIH), disrupting studies and unmooring biomedical and public health research communities.
The first sickle cell disease patient in the St. Louis region has been successfully treated by WashU Medicine physicians at St. Louis Children’s Hospital with a gene therapy newly approved by the Food and Drug Administration.
The effects of a prospective sink environmental hygiene intervention on Pseudomonas aeruginosa and Stenotrophomonas maltophilia burden in hospital sinks Jennie Kwon, DO, MSCI, Associate Professor of Medicine at WashU Medicine’s Division of Infectious Diseases, co-published research in eBioMedicine about the burden of hygiene in hospital sinks. Co-principal investigators are; Gautam Dantas, PhD, Conan Professor of Laboratory and Genomic Medicine, and […]
A new type of immunotherapy that targets aggressive blood cancers shows promising results alongside manageable side effects, according to the results of an international phase 1/2 clinical trial led by researchers at Washington University School of Medicine in St. Louis.
With the U.S. Food and Drug Administration (FDA) approval of transcatheter tricuspid valve replacement (TTVR) and transcatheter edge-to-edge repair (T-TEER) procedures for tricuspid regurgitation treatment, heart specialists at the Washington University and Barnes-Jewish Heart & Vascular Center in St. Louis, Mo., are pioneering advances that enhance the quality of life for patients who have historically suffered debilitating […]
When it comes to questions about fungal infections, Andrej Spec, MD, has become the go-to expert for doctors around the world. Each week, he takes 10 to 15 calls from physicians struggling with complex fungal diagnosis or treatment questions. He has fielded queries from all across the U.S. and as far away as China, Thailand, Japan, […]
In a clinical trial, researchers find moxidectin, a new medicine for river blindness, also works for lymphatic filariasis
An international phase 3 clinical trial led by Washington University School of Medicine in St. Louis and Dana-Farber Brigham Cancer Center shows that patients with certain locally advanced head and neck cancers benefited from the addition of the immunotherapy drug pembrolizumab (brand name Keytruda) to standard-of-care therapy.
A dedicated group of hospitalists are advancing diagnostic excellence under the leadership of Radha Devi, MD, and Timothy Evans, MD, through our Division’s Center for Diagnostic Excellence (DexEx).